| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,021 |
4,684 |
$1.49M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,012 |
2,697 |
$1.01M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,651 |
4,396 |
$654K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,570 |
1,199 |
$132K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
955 |
883 |
$90K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,223 |
1,646 |
$85K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,801 |
1,677 |
$60K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
634 |
552 |
$58K |
| 80053 |
Comprehensive metabolic panel |
7,720 |
6,861 |
$58K |
| 80050 |
General health panel |
1,414 |
1,321 |
$55K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
247 |
224 |
$55K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,964 |
1,751 |
$54K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,621 |
1,439 |
$48K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,609 |
1,429 |
$48K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,614 |
1,429 |
$48K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,383 |
7,370 |
$47K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,014 |
783 |
$41K |
| 71045 |
Radiologic examination, chest; single view |
1,201 |
1,075 |
$39K |
| 80061 |
Lipid panel |
3,308 |
3,084 |
$37K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,601 |
1,448 |
$31K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
936 |
639 |
$30K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
948 |
816 |
$30K |
| 87400 |
|
3,083 |
1,347 |
$25K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,124 |
2,908 |
$25K |
| 70450 |
Computed tomography, head or brain; without contrast material |
197 |
174 |
$21K |
| 36415 |
Collection of venous blood by venipuncture |
8,574 |
6,923 |
$21K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
825 |
769 |
$20K |
| 86780 |
|
1,683 |
1,532 |
$19K |
| 71046 |
Radiologic examination, chest; 2 views |
502 |
470 |
$18K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
190 |
178 |
$16K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,099 |
1,006 |
$15K |
| 76830 |
Ultrasound, transvaginal |
154 |
148 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
439 |
418 |
$13K |
| 87340 |
|
1,463 |
1,321 |
$12K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
163 |
114 |
$11K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
129 |
111 |
$11K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
144 |
102 |
$11K |
| J3410 |
Injection, hydroxyzine hcl, up to 25 mg |
177 |
155 |
$11K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,144 |
952 |
$10K |
| 87653 |
|
327 |
301 |
$10K |
| 86803 |
|
853 |
761 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,269 |
1,130 |
$9K |
| 85027 |
|
1,331 |
1,157 |
$7K |
| 81025 |
|
1,055 |
925 |
$7K |
| 87088 |
|
893 |
788 |
$6K |
| 84484 |
|
842 |
691 |
$5K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
12 |
12 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
44 |
39 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
668 |
596 |
$4K |
| 83880 |
|
222 |
197 |
$4K |
| 86850 |
|
1,276 |
1,071 |
$4K |
| 86762 |
|
344 |
304 |
$4K |
| 71250 |
|
30 |
26 |
$4K |
| 81001 |
|
1,749 |
1,508 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
81 |
73 |
$4K |
| 83021 |
|
204 |
183 |
$3K |
| 86787 |
|
288 |
253 |
$3K |
| 81003 |
|
1,821 |
1,575 |
$3K |
| 86702 |
|
251 |
221 |
$3K |
| 83020 |
|
207 |
183 |
$2K |
| 83690 |
|
510 |
471 |
$2K |
| 86003 |
|
148 |
58 |
$2K |
| 83735 |
|
628 |
556 |
$2K |
| 86900 |
|
1,278 |
1,072 |
$2K |
| 86901 |
|
1,287 |
1,072 |
$2K |
| 59025 |
Fetal non-stress test |
18 |
14 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
890 |
582 |
$2K |
| J2060 |
Injection, lorazepam, 2 mg |
309 |
265 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
301 |
278 |
$2K |
| 82950 |
|
402 |
363 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
133 |
111 |
$2K |
| 86701 |
|
250 |
221 |
$2K |
| C1769 |
Guide wire |
15 |
15 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
723 |
510 |
$1K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
17 |
14 |
$1K |
| 87430 |
|
79 |
77 |
$1K |
| 87807 |
|
92 |
90 |
$1K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18 |
17 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
12 |
12 |
$883.56 |
| 76937 |
|
15 |
12 |
$867.53 |
| 86592 |
|
252 |
221 |
$829.74 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
27 |
25 |
$810.00 |
| 82550 |
|
206 |
177 |
$756.97 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
128 |
109 |
$750.84 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
37 |
37 |
$714.70 |
| 82553 |
|
159 |
133 |
$684.21 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
15 |
15 |
$681.35 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18 |
16 |
$646.00 |
| 85610 |
|
216 |
195 |
$637.17 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
716 |
539 |
$603.46 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
868 |
672 |
$554.38 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
72 |
40 |
$495.62 |
| J1644 |
Injection, heparin sodium, per 1000 units |
52 |
26 |
$438.12 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
581 |
280 |
$404.07 |
| 82105 |
|
27 |
25 |
$402.48 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
45 |
41 |
$384.32 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
12 |
12 |
$346.92 |
| 85730 |
|
83 |
72 |
$325.74 |
| 82150 |
|
68 |
64 |
$324.00 |
| 80055 |
|
15 |
13 |
$289.44 |
| 82728 |
|
24 |
24 |
$286.23 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
20 |
14 |
$280.96 |
| 87486 |
|
14 |
14 |
$280.72 |
| 87581 |
|
14 |
14 |
$280.72 |
| 87081 |
|
49 |
43 |
$271.83 |
| 85384 |
|
36 |
33 |
$254.66 |
| 99153 |
Mod sedat endo service >5yrs |
17 |
12 |
$203.54 |
| 83550 |
|
25 |
25 |
$192.28 |
| 80179 |
|
15 |
14 |
$186.40 |
| 99152 |
|
47 |
40 |
$185.04 |
| 85379 |
|
27 |
25 |
$173.10 |
| 84439 |
|
20 |
19 |
$171.38 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
679 |
318 |
$151.33 |
| 83540 |
|
25 |
25 |
$142.34 |
| 85007 |
|
55 |
52 |
$126.17 |
| 82785 |
|
23 |
12 |
$115.22 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
303 |
231 |
$63.31 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
17 |
14 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
26 |
14 |
$0.00 |